Vascular adventitial fibroblasts (AFs) are important in the homeostasis of vascular structure. This study is designed to investigate the roles of AF exosomes (AFE) in VSMC migration and underling mechanism. Primary VSMCs and AFs were obtained from the aorta of spontaneously hypertensive rats (SHR) and Wistar-Kyoto (WKY) rats. VSMC migration was evaluated with Boyden chamber assay and wound healing assay. AFE from WKY rats and SHR were isolated and identified. AFE from SHR promoted but AFE from WKY rats had no significant effect on VSMC migration. 
V ascular smooth muscle cells (VSMCs) are mainly located in the arterial tunica media, which are critical determinants in vascular disease. 1 VSMC migration is pivotal to extensive intimal thickening that occurs in the progression of atherosclerosis, 2 transplant vasculopathy, 3 stent restenosis, 4 and vascular injury. 5 VSMC migration is involved in hypertensioninduced maladaptive vascular remodeling 6, 7 and contributes to the atherogenic mechanisms in hypertension. 8 In pulmonary arteries, enhanced migration and proliferation of pulmonary arterial smooth muscle cells is a key component of vascular remodeling in the development of pulmonary hypertension. [9] [10] [11] Vascular adventitia acts as a biological processing center for the retrieval, integration, storage, and release of key regulators of vessel wall. 12, 13 The most abundant cell type in vascular adventitia is the fibroblasts that contribute to the maintenance of vascular function and homeostasis. 14 Adventitial fibroblasts (AFs) act as a key regulator of vascular wall function and structure from the outside-in. 15 Excessive adventitial remodeling causes early aortic maladaptation in angiotensin-induced hypertension. 16 In response to vascular stress or injury, the AFs are often the first to be activated for modulating vascular tone and architecture of the vessel wall. AFs play an important role in vascular remodeling and contribute to neointimal formation in vascular diseases. 17, 18 We recently showed that fibronectin type III domain containing 5 attenuates inflammasome activation and phenotypic transformation of AFs in spontaneously hypertensive rats (SHR). 19 It is known that many types of cells release phospholipid membrane vesicles that are thought to play key roles in cell-cell communication. 20, 21 These extracellular vesicles include exosomes and microvesicles. The exosomes refer to endosome-originated membrane vesicles with a diameter of 40 to 150 nm, and the microvesicles are defined as plasma membrane shedding vesicles of 100 to 1000 nm. 22,23 These extracellular vesicles represent an important mode of intercellular communication by serving as vehicles for transfer of proteins, lipids, and RNA. 24 It has been found that AT 1 R (Ang II [angiotensin II] type 1 receptor)-enriched exosomes are released from heart under conditions of in vivo cellular stress to modulate vascular responses to neurohormonal stimulation. 25 Ang II stimulates cardiac fibroblasts to release exosomes, which in turn increase Ang II production and its receptor expression in cardiomyocytes, thereby intensifying Ang II-induced cardiac hypertrophy. 26 It would be interesting to know whether exosome-mediated transfer of Ang II from AFs of SHR is involved in VSMC migration. We found that ACE (angiotensin-converting enzyme) is involved in the exosome-mediated transfer from AFs of SHR instead of Ang II or AT 1 R. The present study is designed to investigate roles of AF exosomes (AFE) in VSMC migration and underlying mechanism.
Methods
The data that support the findings of this study are available from the corresponding author on reasonable request. A full methodology is provided in the online-only Data Supplement. In brief, primary AFs and VSMCs were isolated and prepared from thoracic aorta of male Wistar-Kyoto (WKY) rats and SHR aged 8 weeks.
27,28 AFE from WKY rats and AFE from SHR were isolated and purified with PureExo Exosome Isolation Kit (101Bio, Palo Alto, CA). [29] [30] [31] AFE were characterized with transmission electron microscopy and Nanoparticle Tracking Analysis and were identified with the expressions of exosome-associated protein markers CD9 and CD63 without the expression of negative markers calnexin. 26, 32 Migration of VSMCs from WKY rats and VSMCs from SHR was evaluated with both Boyden chamber assay and Wound healing assay. 33 The trial was performed in a double-blinded and randomized fashion.
Statistics and Data Analysis
Data are presented as means±SE. Comparisons between 2 groups were made by Student unpaired t test. One-way or 2-way ANOVA followed by post hoc Bonferroni test was used when multiple comparisons were made. A value of P<0.05 was considered statistically significant.
Results

Exosome Inhibitor GW4869 Prevents VSMC Migration Induced by Condition Medium of AFs of SHR
AFs condition medium was added to VSMC medium to determine the role of AFs in VSMC migration. AFs of SHR increased the number of migrated VSMCs ( Figure 1A ) and migrated distance of VSMCs ( Figure 1B) . However, AFs of WKY rats had no significant effect on VSMC migration. GW4869 is a neutral sphingomyelinase inhibitor. The cellpermeable pharmacological agent is the most widely used as an exosome inhibitor for blocking exosome generation in macrophages, HEK293 (human embryonic kidney 293) cells, cardiomyocytes, liver cells, and lung epithelial cells. 34 In this study, we sought to determine if blockade of exosome generation would prevent the AFs-induced VSMC migration with 20 μmol/L of GW4869. This concentration of GW4869 can effectively inhibit exosome generation without toxic effects on cells. 34 Pretreatment with GW4869 prevents the VSMC migration effect of AFs from SHR ( Figure 1A and 1B). These findings suggest that AFs from SHR stimulates VSMC migration, probably mediated through AFE, which was supported by the findings that the supernatant of AFs condition medium after ultracentrifugation to remove exosomes had no significant effect on VSMC migration ( Figure S1 ).
Characterization of AFs-Derived Exosomes
AFE from aorta of WKY rats and SHR were isolated and purified with PureExo Exosome Isolation Kit. Transmission electron microscopic images showed that most of the isolated vesicles from AFs had a spherical or cup-shaped morphology ( Figure 2A ). Nanoparticle Tracking Analysis showed a typical exosome preparation with an average size of 94 nm (a major population at 82-105 nm), which are characteristic features of most exosomes ( Figure 2B) . 22, 23 Concentration of exosomes isolated with the Isolation Kit was (17.4±3.7)×10 6 particles/ mL or (17.8±3.8)×10
6 particles/mg protein. The vesicles contained the established exosome-associated protein markers, such as CD9 and CD63, but were negative for calnexin ( Figure 2C ), a protein which is not expressed in exosomes. 26 These results indicated that the isolated vesicles released from AFs of rats are exosomes.
AFE of SHR Promotes VSMC Migration
AFE of SHR concentration-dependently increased the migrated distance of VSMCs from WKY rats, almost reaching its maximal effects at the concentration of 30 μg protein/mL in the culture media ( Figure S2 ). Therefore, 30 μg protein/mL (0.54×10 6 particles/mL) of AFE in the culture media were used in the following experiments. VSMC migration was faster in VSMCs of SHR than those of WKY rats evidenced by the increased number of migrated VSMCs and migrated distance. AFE of WKY rats had no significant effects on VSMC migration, whereas AFE of SHR promotes VSMC migration in the VSMCs from both WKY rats and SHR ( Figure 2D and 2E).
AT 1 R and ACE in AFE-Induced VSMC Migration
Based on the findings that AT 1 R-enriched exosomes released from the heart were involved in cardiovascular function, 25 we further investigated whether blockade of AT 1 R or inhibition of ACE attenuates AFE-induced VSMC migration. Losartan, an AT 1 R antagonist, inhibited the accelerated VSMC migration in VSMCs from SHR but had no significant effects in those from WKY rats. AFE of SHR significantly promoted VSMC migration in the VSMCs from WKY rats or SHR, which were inhibited by the pretreatment with an AT 1 R antagonist losartan ( Figure 3A and 3B) . Unexpectedly, inhibition of ACE with captopril also attenuated the effects of AFE on VSMC migration in VSMCs from WKY rats or SHR ( Figure 3C and 3D), reaching its maximal effect at the concentration ≈200 μmol/L ( Figure S3 ).
Ang II, AT 1 R, and ACE Levels and ACE Activity in AFE
There were no significant difference in mRNA levels of AGT (angiotensinogen), AT 1 R, and ACE between the AFE from WKY rats and the AFE from SHR ( Figure 4A) . Interestingly, the ACE contents in AFE from SHR were ≈3.3× higher than those in AFE from WKY rats, but the Ang II and AT 1 R contents in AFE from SHR were not higher than those in AFE from WKY rats ( Figure 4B ). Consistent with ACE contents, ACE activity in AFE from SHR was ≈5.6× than those in AFE from WKY rats ( Figure 4C ). These results suggest that increased ACE contents and ACE activity in AFE from SHR were at least partially responsible for their VSMC migration effect. After removing exosomes from the AFE solution with ultracentrifugation method, the ACE level in the supernatant was undetectable measured with Elisa assay. The results suggest that the ACE exists in the AFE rather than out of AFE.
ACE Expressions and ACE Activity in AFs and VSMCs
ACE mRNA and protein expressions and ACE activity were increased in AFs of SHR but not significantly increased in VSMCs of SHR compared with those in WKY rats. However, the ACE mRNA and protein expressions and ACE activity in VSMCs of SHR were lower than AFs of SHR ( Figure 4D ). The increased ACE expression in AFs of SHR may be related to the increased ACE contents in AFE from SHR.
Effects of Captopril on AFE-Induced AT 1 R, Ang II, and ACE Changes in VSMCs
AFE from SHR had no significant effects on AT 1 R protein and ACE mRNA levels, but increased ACE contents in VSMCs of WKY rats or SHR, which were not affected by pretreatment of VSMCs with captopril ( Figure 5A-5C) . However, the increases of ACE activity and Ang II contents in VSMCs of WKY rats or SHR induced by the AFE from SHR were prevented by pretreatment of VSMCs with captopril ( Figure 5D and 5E). These results suggest that AFE from SHR increases the Ang II levels in VSMCs via exosome-mediated ACE transfer from AFs to VSMCs. A previous study has shown that some commercially available AT 1 R antibodies fail to detect AT 1 R and instead provide a band for an unknown protein. 35 Our previous study has showed that a recombinant Ad-miR-AT 1 R (adenoviral vectors expressing artificial microRNA targeting AT 1 receptor) effectively reduces AT 1 R expression. 36 This Ad-miR-AT 1 R in VSMCs significantly reduced AT 1 R expression measured with the AT 1 R ELISA kit (LifeSpan Biosciences, Catalog no. LS-F49283) and AT 1 R antibody (Abcam, Catalog no. ab124734) used in this study ( Figure  S4 ). The findings support the results about the AT 1 R levels measured with AT 1 R ELISA kit and AT 1 R antibody in the present study. Furthermore, the AT 1 R ELISA kit is used for detection of rat AT 1 R, and no significant cross-reactivity or interference between AT 1 R and analogs was observed according to the User Manual.
ACE Knockdown in AFs Reduces ACE Contents and Activity in AFE of SHR
AFE from SHR was prepared 5 days after addition of ACEsiRNA (small interfering RNA) into AFs of SHR. ACE knockdown in AFs of SHR reduced ACE contents and activity, as well as Ang II contents in AFs of SHR, indicating the effectiveness of ACE knockdown. There were much higher ACE contents and activity but lower Ang II contents in AFE from SHR than those in AFs from SHR. ACE knockdown in AFs of SHR greatly reduced ACE contents and activity but had no significant effects on Ang II contents in AFE of SHR ( Figure 6A and 6B) . Furthermore, ACE knockdown reduced ACE protein levels examined with Western blot in both AFs and AFE of SHR ( Figure S5 ). These results suggest that AFE of SHR selectively transfer ACE rather than Ang II from AFs to VSMCs.
ACE Knockdown in AFs Inhibits VSMC Migration Induced by AFE From SHR
ACE knockdown was performed by administration of ACEsiRNA in AFs of SHR. Five days later, AFE from SHR was prepared from the AFs and was added into VSMCs of WKY rats or SHR. ACE knockdown prevents the AFE-induced migration of VSMCs of WKY rats or SHR, evidenced by the reduced number of migrated VSMCs and migrated distance ( Figure 6C and 6D) . These results suggest that intervention of ACE expression in the AFs inhibit VSMC migration induced by AFE from SHR.
Effects of AFE Isolated With Ultracentrifugation Method
The effects of AFE isolated with ultracentrifugation method were examined to exclude the possibility that the effects may be caused by an artifact of isolation process with the PureExo Exosome Isolation Kit. The expressions of CD9 and CD63, exosome-associated protein markers, indicated that the isolated vesicles were exosomes ( Figure S6 ). ACE protein levels and activity in AFE from SHR were much higher than AFE from WKY rats ( Figure S7 ). AFE from SHR promoted the migration of VSMCs of WKY rats and SHR, which were inhibited by captopril ( Figure S8 ). These results confirm the findings in AFE isolated with PureExo Exosome Isolation Kit.
Discussion
VSMC migration is a normal process that occurs during vascular development or for tissue repair in response to vascular injury. Pathological migration is a major factor in maladaptive vascular remodeling in hypertension, atherogenesis, and restenosis. 6, 7 Vascular adventitia acts as a principal injurysensing tissue of vessel wall. In response to vascular injury or stress, AFs are often the first to be activated and reprogrammed to influence structure and function of vascular wall, including media of artery. 12 However, the means by which AFs affect VSMCs is unknown. We found that condition medium of AFs of SHR promoted VSMC migration, which almost prevented by an exosome inhibitor GW4869, suggesting that exosomes derived from AFs of SHR primarily mediate the effect of AFs on VSMC migration. Then, we successfully isolated vesicles from AFs, and vesicles were identified as exosomes with transmission electron microscopy, Nanoparticle Tracking Analysis, and specific exosome markers, CD9 and CD63. Just as expected, the exosomes from SHR promotes migration of VSMCs of WKY rats or SHR. It is noted that condition medium of AFs from SHR rather than those from WKY promoted VSMC migration. Similarly, exosomes from SHR but not from WKY rats promoted VSMC migration. The results suggest that the AFE mediates the effects of AFs of SHR in promoting VSMC migration. AFE of SHR is crucial for the accelerated VSMC migration and thereby contributes to vascular remodeling in hypertension.
Ang II is generated via proteolytic cleavage of Ang I by ACE and is involved in cardiovascular remodeling in hypertension. [37] [38] [39] Ang II is vital in promoting VSMC migration primarily mediated by AT 1 R and its downstream MAPK (mitogen-activated protein kinase) pathway. 40 At the vascular level, with the exception of renin, all other components of the angiotensin system are locally produced in vascular adventitia, smooth muscle cells, or endothelial cells. 41 It is known that Ang II and aldosterone synergistically stimulate VSMC migration. 42 We found that ACE contents and activity were much higher in the AFE from SHR than those from WKY rats. There was no significant difference in the levels of Ang II, AT 1 R, and ACE mRNA, as well as the contents of Ang II and AT 1 R between the AFE from SHR and the AFE from WKY rats. AFE from SHR increased the ACE and Ang II contents and ACE activity in VSMCs of WKY rats and SHR. Inhibition of ACE prevents the AFE-induced increases in ACE activity and Ang II contents. More importantly, either blockade of AT 1 R or inhibition of ACE attenuated the promoting effect of AFE from SHR on VSMC migration. These findings provide solid evidence that the AFs of SHR increase the ACE contents and activity in VSMCs via AFE-mediated transfer of ACE, which causes more Ang II generation and AT 1 R activation, and then promote VSMC migration. Inhibition of ACE in VSMCs attenuates VSMC migration caused by AFE from SHR. AFE-mediated ACE transfer is a primary mechanism of AFs of SHR in promoting VSMC migration. Although AT 1 Renriched exosomes released from heart under cellular stress contributes to vascular responses, 25 AT 1 Rs are not involved in the exosomes transfer from AFs.
ACE mRNA and protein expressions and ACE activity in AFs were higher in SHR than those in WKY rats. Knockdown of ACE in AFs of SHR reduced ACE contents and activity not only in AFs of SHR but also in AFE from SHR. The findings suggest that the increased expressions of ACE in AFS of SHR are at least partially responsible for the increased ACE contents in AFE of SHR. The ACE is not simply or passively but selectively packaged in the AFE, evidenced by facts that ACE contents and activity were higher in AFE from SHR than those in AFs of SHR, and Ang II contents were lower in AFE from SHR than those in AFs of SHR. However, ACE expression and activity were lower in VSMCs of SHR than those in AFs of SHR, which may favor to the regulatory effect of AFE-mediated transfer of ACE on VSMC migration. More importantly, knockdown of ACE in AFs of SHR inhibits the effects of the AFE-mediated acceleration of VSMC migration, indicating the key role of the ACE-enriched exosomes released from AFs of SHR in promoting VSMC migration. ACE inhibitor and AT 1 R antagonist are widely used for the treatment of hypertension. 43 Blockade of the effects of AFEmediated ACE transfer may be one of their important pharmacological roles.
Perspectives
AFs of SHR promotes VSMC migration via exosome-mediated ACE transfer. Higher ACE levels in AFE of SHR are responsible for the increased ACE contents and activity, which causes more Ang II generation and AT 1 R activation, followed by accelerated VSMC migration. Knockdown of ACE in AFs inhibits VSMC migration induced by AFE from SHR. We think that intervention of AFE-mediated transfer of ACE and inhibition of ACE expression in AFs might be effective therapeutic strategies in attenuating VSMC migration in hypertension or other vascular diseases.
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